✦ LIBER ✦

Single-Institution Experience with Pemetrexedand Bevacizumab as Salvage Therapy in AdvancedNon–Small-Cell Lung Cancer

✍ Scribed by Glen J. Weiss; Chan Zeng; Karen Kelly; Zung Vu Tran; Paul A. Bunn Jr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin/Pemetrexed/Bevacizumab in th

✍ Binu Malhotra; Tracey Evans; Jared Weiss; Beth Eaby; Susan Stonehouse-Lee; Victo 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 121 KB

212 Contemporary single institution expe

✍ Okiror, L.; Karenovics, W.; Bille, A.; Harrison-Phipps, K.; King, J.; Lang-Lazdu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

90P ERLOTINIB VS CHEMOTHERAPY AS SECOND

✍ Garde, J.; García, J.; Berzosa, M.; Marin, S.; Sangrador, C.; Piera, N.; Hidalgo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

P0153 Toxicity of vinorelbine with plati

✍ Jegannathen, A.; Giridharan, S.; Morgan Lovatt, R.; Sulé-Suso, J.; Gilani, S. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Concurrent Hyperfractionated Radiation T

✍ Branislav Jeremić; Biljana Miličić; Slobodan Milisavljevic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Single agent gefitinib as first line the

✍ Kommareddy, Aruna; Coplin, Margaret A; Gao, Feng; Behnken, Danelle; Romvari, Edi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 83 KB